---
title: Clinical Case Conference
subtitle: General Cardiology Lecture Series 
author: Anish S. Shah, MD, MS
institute: Division of Cardiology, Department of Medicine, University of Illinois Chicago 
date: April 8, 2024
format:
  revealjs:
    transition: fade
    transition-speed: fast
    slide-number: true
    incremental: true
    auto-animate-easing: ease-in-out
    auto-animate-unmatched: false
    progress: true
    chalkboard: true
    scrollable: true

csl: ../../apa.csl
---


# Introduction

## Objectives

1. Understand the __cognitive processes__ involved in the case-based diagnostic reasoning 
1. Identify __diagnostic assumptions__ that may lead towards case-specific biases
1. Practice __contextualizing clinical data__ in the framework of cardiovascular physiology

# History & Physical

---

[30 year old gentleman with a history of acid reflux on PPI therapy, generalized anxiety disorder without long-term therapy, exercise-induced asthma on SABA inhaler therapy.]{.center}

---

He had recurrent episodes of wheezing and cough over past 4-6 months, and was sent to the emergency room after being found to have a arterial saturation of 87% on room air.

. . .

Reports that he most prominently noted his dyspnea during sexual intercourse with his wife.

---

He improved with nebulizer therapy. 
Was seen by ENT at similar time, noting no upper respiratory causes for his symptoms.

. . .

Electrocardiography and chest roengenography was performed during his ER visit.

# Electrocardiography 

## {background-image="ecg-initial-pvc.png" background-size="contain"}

## {background-image="ecg-subsequent-pac.png" background-size="contain"}

# Chest Roentgenography

## {background-image="cxr-ap.gif" background-size="contain"}

## Problems {.smallest}

:::: {.columns}

::: {.column width="65%"}

::: {.fragment fragment-index=1}
Sinus tachycardia
:::

::: {.fragment fragment-index=2}
::: {.fragment .semi-fade-out fragment-index=6}
Right axis deviation with inferior [qR]{.red} and lateral [rS]{.red} pattern
:::
:::

::: {.fragment fragment-index=3}
::: {.fragment .semi-fade-out fragment-index=7}
[Complete interpolation]{.red} of ventricular ectopy with [superior axis]{.red} and inverted [transition at V2-V3]{.red}
:::
:::

::: {.fragment fragment-index=4}
::: {.fragment .semi-fade-out fragment-index=8}
Enlarged left-sided heart border with narrow vascular pedicle
:::
:::

::: {.fragment fragment-index=5}
::: {.fragment .semi-fade-out fragment-index=9}
[Earlier]{.red} completely interpolated atrial depolarizations, as compared with PVC, at [similar cycle length]{.red}.
:::
:::

:::

::: {.column width="35%"}

::: {.fragment fragment-index=6}
::: {.fragment .highlight-current-red fragment-index=6}
Left posterior fascicular block
:::
:::

::: {.fragment fragment-index=7}
::: {.fragment .highlight-current-red fragment-index=7}
Inferior/posterior-septal PVC
:::
:::

::: {.fragment fragment-index=8}
::: {.fragment .highlight-current-red fragment-index=8}
Cardiomegaly
:::
:::

::: {.fragment fragment-index=9}
::: {.fragment .highlight-current-red fragment-index=9}
*Poor or abnormal VA conduction?*
:::
:::

:::

::::


---

Patient describes a 10+ year history of anabolic steroid usage, initiated by his coach while he trained as a body-builder. 

. . .

He continued as he was unsure on how to taper.

. . .

He had been on multiple testosterone and anabolic steroid supplements, and had most recently (past 3-6 months) trialed growth hormone.

. . .

Growth hormone was stopped due to lower extremity and hand swelling.

## Additional histories

. . .

Maternal grandfather died of sudden death at age 40, and mother has a potential "mitral valve prolapse". 
Father was a body-builder and had taken steroids previously.
No foreign travel, raised in Canada and lives in Chicago currently. 

. . .

No pets. Has a *1-year old son with his wife*, who are both healthy.

## Medications

- Chlorodehydromethyltestosterone (CDMT, a.k.a. *turinabol*) 
- Oxandrolone (active)
- Testosterone supplementation (active)
- Growth hormone injections (for 3-6 months prior to presentation)
- Albuterol inhaler PRN
- Omeprazole 40 mg PO daily

## Examination

. . .

Initial vitals of 173/92 and heart rate of 122 bpm that decreased to 137/75 and 109 bpm after rest. SaO2 of 94-96% on room air. BMI 28, 93 kg.

. . .

Anxious appearing young gentleman, mildly pressured speech. Skin is warm and dry, Fitzpatrick class I. Mild androgenic alopecia. Not overly-muscular.

. . .

JVP at level of clavicle at 30Ëš. Normal carotid upstroke. PMI is laterally displaced. No obvious thrills or heaves. S1 with physiologically split S2. III/VI systolic murmur apparent at axilla. No peripheral edema, with +2 radial and posterior tibialis pulses.

## Labs

:::: {.columns}
::: {.column width="50%"}

::: {.fragment fragment-index=1}
Sodium 138  
Potassium 4.0   
Chloride 102   
CO2 24   
BUN 29  

::: {.fragment .highlight-red fragment-index=3}
Creatinine 1.96  
:::   

AST 35  

::: {.fragment .highlight-red fragment-index=3}
ALT 52   
:::  
:::

:::
::: {.column width="50%"}

::: {.fragment fragment-index=2}
Hg 17.5   
WBC 8 (normal differential)  
PLT 208  
HbA1c 5.2%

::: {.fragment .highlight-red fragment-index=3}
LDL 165, HDL 34   
Troponin I 105 (ng/L)  
BNP 289  
:::

UDS negative  
:::

:::
::::

# Surface Echocardiography

## {background-image="tte-plax.gif" background-size="contain"}
## {background-image="tte-plax-zoom.gif" background-size="contain"}
## {background-image="tte-plax-zoom-color.gif" background-size="contain"}
## {background-image="tte-plax-lvidd.gif" background-size="contain"}
## {background-image="tte-psax-mid.gif" background-size="contain"}
## {background-image="tte-psax-mv.gif" background-size="contain"}
## {background-image="tte-psax-mv-color.gif" background-size="contain"}
## {background-image="tte-rv-inflow-color.gif" background-size="contain"}
## {background-image="tte-rv-inflow-cw.gif" background-size="contain"}

## {background-image="tte-psax-high.gif" background-size="contain"}
## {background-image="tte-psax-high-rv-inflow-pw.gif" background-size="contain"}
## {background-image="tte-psax-high-rv-outflow-cw.gif" background-size="contain"}
## {background-image="tte-psax-high-rv-outflow-pw.gif" background-size="contain"}

## {background-image="tte-rv-outflow.gif" background-size="contain"}
## {background-image="tte-rv-outflow-cw-vti.gif" background-size="contain"}
## {background-image="tte-rv-outflow-pw-vti.gif" background-size="contain"}

## {background-image="tte-a4c.gif" background-size="contain"}
## {background-image="tte-a4c-color.gif" background-size="contain"}
## {background-image="tte-a4c-color-2.gif" background-size="contain"}
## {background-image="tte-a4c-mv-color.gif" background-size="contain"}
## {background-image="tte-a4c-mitral-inflow-pw.gif" background-size="contain"}
## {background-image="tte-a4c-td-lateral.gif" background-size="contain"}
## {background-image="tte-a4c-td-septal.gif" background-size="contain"}
## {background-image="tte-a4c-m-mode-color.gif" background-size="contain"}
## {background-image="tte-a4c-zoom.gif" background-size="contain"}
## {background-image="tte-a4c-thrombus.gif" background-size="contain"}
## {background-image="tte-a2c.gif" background-size="contain"}
## {background-image="tte-a3c.gif" background-size="contain"}
## {background-image="tte-a5c-color.gif" background-size="contain"}
## {background-image="tte-a5c-cw.gif" background-size="contain"}
## {background-image="tte-a5c-pw.gif" background-size="contain"}
## {background-image="tte-a2c-definity.gif" background-size="contain"}


## Problems {.smallest}

:::: {.columns}
::: {.column width="65%"}

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=8}
Severely reduced LV systolic function with [EF < 20%]{.red}
:::
:::

::: {.fragment fragment-index=2}
::: {.fragment .semi-fade-out fragment-index=9}
LV cavity during diastole of [~7.5 cm]{.red}
:::
:::

::: {.fragment fragment-index=3}
::: {.fragment .semi-fade-out fragment-index=11}
LVOT VTI of [9 cm]{.red} and RVOT VTI of [6 cm]{.red}
:::
:::

::: {.fragment fragment-index=4}
::: {.fragment .semi-fade-out fragment-index=8}
Regional wall motion abnormalities with [inferior hypokinesis/akinesis]{.red}
:::
:::

::: {.fragment fragment-index=5}
::: {.fragment .semi-fade-out fragment-index=10}
Moderate to [severe mitral regurgitation]{.red}
:::
:::

::: {.fragment fragment-index=6}
::: {.fragment .semi-fade-out fragment-index=12}
[Echodensity]{.red} in apex
:::
:::

::: {.fragment fragment-index=7}
::: {.fragment .semi-fade-out fragment-index=8}
Grade III diastolic dysfunction
:::
:::

:::
::: {.column width="35%"}

Left posterior fascicular block  
Inferior/posterior septal PVC

::: {.fragment .fade-out fragment-index=9}
Cardiomegaly
:::

::: {.fragment fragment-index=8}
::: {.fragment .highlight-current-red fragment-index=8}
Severe systolic dysfunction 
:::
:::

::: {.fragment fragment-index=9}
::: {.fragment .highlight-current-red fragment-index=9}
Dilated cardiomyopathy
:::
:::

::: {.fragment fragment-index=10}
::: {.fragment .highlight-current-red fragment-index=10}
Mitral regurgitation IIIb 
:::
:::

::: {.fragment fragment-index=11}
::: {.fragment .highlight-current-red fragment-index=11}
Low cardiac output state
:::
:::

::: {.fragment fragment-index=12}
::: {.fragment .highlight-current-red fragment-index=12}
Apical thrombus
:::
:::

:::
::::

## Differential {.smallest}

:::: {.columns}
::: {.column width="33%"}

::: {.fragment fragment-index=1}
__[Genetic]{.underline}__
:::

::: {.fragment fragment-index=2}
TTN   
LMNA   
MYH7   
FLNC (filamin C)  
RBM20 (RNA-binding motif-20)  
TNNT2  
TTNC1  
PLN (phospholamban)  
DSP (desmoplakin)  
ACTC1  
SCN5A  
TPM1 (tropomyosin)  
:::

:::
::: {.column width="33%"}

::: {.fragment fragment-index=3}
__[Infectious]{.underline}__
:::

::: {.fragment fragment-index=4}
COVID/viral myocarditis  
Chagas disease  
Endomyocardial fibrosis  
:::

::: {.fragment fragment-index=5}
__[Immune-mediated]{.underline}__
:::

::: {.fragment fragment-index=6}
Giant-cell myocarditis  
Eosinophilic myocarditis  
Sarcoidosis  
:::

::: {.fragment fragment-index=7}
__[Ischemic]{.underline}__
:::

::: {.fragment fragment-index=8}
Plaque rupture syndrome  
Coronary artery spasm  
Spontaneous coronary artery dissection  
:::

:::
::: {.column width="33%"}


::: {.fragment fragment-index=9}
__[Others]{.underline}__
:::

::: {.fragment fragment-index=10}
Thiamine deficiency (beri-beri)  
Selenium deficiency  
Hypocalcemia  
Hyper/hypo-thyroidism  
Tachycardia-induced  
Alcohol-induced  
Amphetamine-induced  
Catecholamine-induced (stress-induced, e.g. *Takotsubo*)  
Anabolic steroid-induced  
Hemochromatosis  
Wilson's disease  
:::

:::
::::

## {background-image="sliwa-2023-tropical-cardiomyopathy-map.jpg" background-size="contain"}

::: footer
@Sliwa2023
:::

## Additional Labs {.smaller}

:::: {.columns}
::: {.column width="50%"}

TSH/T4 normal  

::: {.fragment .highlight-current-red}
ACTH 20.4   
Free cortisol 1.0  
AM cortisol 13   
FSH < 0.2  
LH < 0.2  
Testosterone 1445 ng/dL  
:::
Lp(a) 21, ApoB100 126 (mg/dL)  
Cystatin 0.9 (eGFR 81)  

:::
::: {.column width="50%"}

Ferritin 194   
Iron 70   
Normal cerruloplasmin  
TB negative  
HIV negative  
RVP negative  
Hepatitis panel negative  
Trypanasoma cruzi IgG negative  
ANA/Anti-SM negative  
SPEP/UPEP negative  

:::
::::

## Differential {.smallest}

:::: {.columns}
::: {.column width="33%"}

::: {.fragment fragment-index=1}
__[Genetic]{.underline}__
:::

::: {.fragment fragment-index=1}
TTN   
LMNA   
MYH7   
FLNC (filamin C)  
RBM20 (RNA-binding motif-20)  
TNNT2  
TTNC1  
PLN (phospholamban)  
DSP (desmoplakin)  
ACTC1  
SCN5A  
TPM1 (tropomyosin)  
:::

:::
::: {.column width="33%"}

::: {.fragment fragment-index=1}
__[Infectious]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=2}
COVID/viral myocarditis  
Chagas disease  
Endomyocardial fibrosis  
:::
:::

::: {.fragment fragment-index=1}
__[Immune-mediated]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=3}
Giant-cell myocarditis  
Eosinophilic myocarditis  
Sarcoidosis  
:::
:::

::: {.fragment fragment-index=1}
__[Ischemic]{.underline}__
:::

::: {.fragment fragment-index=1}
Plaque rupture syndrome  
Coronary artery spasm  
Spontaneous coronary artery dissection  
:::

:::
::: {.column width="33%"}


::: {.fragment fragment-index=1}
__[Others]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=4}
Thiamine deficiency (beri-beri)  
Selenium deficiency  
Hypocalcemia  
Hyper/hypo-thyroidism  
:::
Tachycardia-induced  

::: {.fragment .semi-fade-out fragment-index=5}
Alcohol-induced  
Amphetamine-induced  
Catecholamine-induced (stress-induced, e.g. *Takotsubo*)  
:::

Anabolic steroid-induced  

::: {.fragment .semi-fade-out fragment-index=6}
Hemochromatosis  
Wilson's disease  
:::
:::

:::
::::

---

::: {.r-fit-text}
1. Steroid-induced cardiomyopathy    
1. Genetic/dilated cardiomyopathy  
1. Tachycardia-mediated cardiomyopathy   
1. Ischemic cardiomyopathy  
:::

## Steroid-induced cardiomyopathy

. . .

Anabolic-androgenic steroid (__AAS__) misuse, above that of replacement hormone levels, is common - up to 2% of men in the US [@Pope2014]

. . .

AAS abuse tends to involve dosing 5-30 times greater than recommended by the Endocrine Society [@Garner2018].

. . . 

In a small study (n = 140), AAS users had an [LVEF 10% lower]{.red} than age-matched non-users [@Baggish2017].

---

![](baggish-2017-box-plot-aas-lvef.png)

::: footer
@Baggish2017
:::

## AAS agents? {.smaller}

- Testosterone is predominately bound to sex hormone-binding globulin, with only 1-2% being free
- Once bound to androgen receptors, initiates gene transcription
- AAS agents mimic testosterone, but maximize *anabolic* effect and minimize *androgenic* effects
- Available orally or as injectable agents
- Used in "cycles" however can become dependent, develop tolerance and have withdrawal with cessation [@Garner2018]
- Additional effect leads to dyslipidemia with high LDL and lower HDL, including increased coronary plaque volume [@Fadah2023]

---

![](fadah-2023-aas-diagram.png)

::: footer
@Fadah2023
:::

## But the growth hormone? {.smaller}

- Growth hormone deficiency is common in heart failure
- @Salzano2018 reviewed studies on the effect on treatment with growth hormone on cardiac function, however mixed results:
  - Improved functional class and exercise duration/capacity
  - Improved VO2
  - Decreased LV size, reverse remodeling, and improved LVEF
  - Decrease HF-associated inflammatory cytokines
- *Did on-and-off growth hormone mask some of the effects of AAS?*

---

![](salzano-2018-gh-mechanism.png)

::: footer
@Salzano2018
:::

# Cardiac catheterization

[Right/left heart catherization with selective coronary angiography]{.center}

## {background-image="cath-pressures.png" background-size="contain"}
## {background-image="cath-report.png" background-size="contain"}
## {background-image="cath-lca-lao-cran.gif" background-size="contain"}
## {background-image="cath-lca-rao-caud.gif" background-size="contain"}
## {background-image="cath-rca-lao-ap.gif" background-size="contain"}
## {background-image="cath-rca-lao-caud.gif" background-size="contain"}

## Problems {.smallest}

:::: {.columns}
::: {.column width="65%"}

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=4}
Hypovolemic "shock" [requiring nor epinephrine]{.red} with light sedation
:::
:::

::: {.fragment fragment-index=2}
::: {.fragment .semi-fade-out fragment-index=5}
Large diameter coronary vessels (4-5 mm) without obstructive disease
:::
:::

::: {.fragment fragment-index=3}
::: {.fragment .semi-fade-out fragment-index=5}
[Diffuse ectasia of RCA]{.red} with diminutive branch vessels
:::
:::

:::
::: {.column width="35%"}

Left posterior fascicular block  
Inferior/posterior septal PVC  
Severe systolic dysfunction   
Dilated cardiomyopathy  
Mitral regurgitation IIIb   

::: {.fragment .highlight-current-red fragment-index=4}
Low cardiac output state  
:::
Apical thrombus  

::: {.fragment fragment-index=5}
::: {.fragment .highlight-current-red fragment-index=5}
Spontaneous coronary artery dissection?
:::
:::

:::
::::

## Arterial pressure and resistance training 

. . .

@MacDougall1985 tested the acute hypertensing response to resistance training, with invasive brachial artery pressure transduction.

- Single-arm curls of 255/190
- Double-leg press of 320/250 (peak 480/350)

## {.center}

![](macdougall-1985-sbp-exercise.png)

::: footer
@MacDougall1985
:::

## {.smaller}

Rare cases of SCAD seen with resistance training [@Aghasadeghi2008]

. . .

@Fahmy2016 described a population of men and women with SCAD. Men (v. women) had a higher rate of...

- Being younger
- Isometric exercise
- Heavy-weight resistance training
- Recreational drugs

---

![](aghasadeghi-2008-rca-scad.jpg)

::: footer
@Aghasadeghi2008
:::

# Cardiac Magnetic Resonance Imaging

## Cine imaging {.smaller}

. . .

Generally, steady-state free precession (__SSFP__) is used in the generation of __cine__ imaging.

. . .

RF pulses produce free induction decay curves or signals, and corresponding echos. 
When in rapid sequence, the signal will began to merge and never reach zero, achieving a *continuous signal of varying amplitude* $\rightarrow$ __SSFP__.

. . .

For CMR, these sequences are repeated throughout a cardiac cycle.

## {background-image="cmr-localizer.gif" background-size="contain"}
## {background-image="cmr-2c-cine.gif" background-size="contain"}
## {background-image="cmr-3c-cine.gif" background-size="contain"}
## {background-image="cmr-4c-cine.gif" background-size="contain"}

## {.center}

::: {layout-nrow=2}
![](cmr-sa-stack-2.gif)
![](cmr-sa-stack-3.gif)
![](cmr-sa-stack-4.gif)
![](cmr-sa-stack-5.gif)
![](cmr-sa-stack-6.gif)
![](cmr-sa-stack-7.gif)
:::

## {.center}

::: {layout-nrow=2}
![](cmr-sa-stack-8.gif)
![](cmr-sa-stack-9.gif)
![](cmr-sa-stack-10.gif)
![](cmr-sa-stack-11.gif)
![](cmr-sa-stack-12.gif)
![](cmr-sa-stack-13.gif)
:::

## {.center}

::: {layout-nrow=1}
![](cmr-av-pc-all.gif)
![](cmr-av-pc-high.gif)
![](cmr-av-pc-low.gif)
:::

## {.center}

::: {layout-nrow=1}
![](cmr-av-cine.gif){width=45%}
![](cmr-cor-lvot-cine.gif){width=45%}
:::

## Gadolinium contrast!

. . .

Gadolinium (__Gd__) is a *paramagnetic* substance (becomes temporarily magnetized), out of four elements (Fe, Ni, Co).
__Gd__ induces __T1 relaxation__. 

. . .

__T1__ is the time it takes for net magnetization to return to initial maximum value (shortened by __Gd__).

. . .

Initially, T1 scouting identifies the inversion time at which viable myocardium is "dark".

---

![](elster-2015-mri-psir-faq.gif)

::: footer
https://mriquestions.com/ps-phase-sensitive-ir.html
:::

---

## {background-image="cmr-t1-scout.gif" background-size="contain"}
## {background-image="cmr-mag-ir-280-sa.gif" background-size="contain"}
## {background-image="cmr-mag-ir-280-4c.gif" background-size="contain"}
## {background-image="cmr-mag-ir-280-2c.gif" background-size="contain"}
## {background-image="cmr-mag-ir-280-3c.gif" background-size="contain"}

---

Phase-corrected inversion recovery sequences are less reliant on a set inversion time

. . .

Next sequence is done with free-breathing.

---

## {background-image="cmr-psir-fb-avg-sa.gif" background-size="contain"}

## Problems {.smallest}

:::: {.columns}
::: {.column width="65%"}

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=5}
Dilated LV with [severely reduced LV function]{.red}
:::
:::

::: {.fragment fragment-index=2}
::: {.fragment .semi-fade-out fragment-index=5}
Inferior wall [akinesis]{.red}
:::
:::

::: {.fragment fragment-index=3}
::: {.fragment .semi-fade-out fragment-index=7}
Inferior wall showed [transmural, from base to apex]{.red} late gadolinium enhancement
:::
:::

::: {.fragment fragment-index=4}
::: {.fragment .semi-fade-out fragment-index=6}
[Thrombus]{.red} seen in the apex
:::
:::

:::
::: {.column width="35%"}

Left posterior fascicular block  
Inferior/posterior septal PVC  

::: {.fragment .highlight-current-red fragment-index=5}
Severe systolic dysfunction   
Dilated cardiomyopathy  
:::
Mitral regurgitation IIIb   
Low cardiac output state  

::: {.fragment .highlight-current-red fragment-index=6}
Apical thrombus  
:::

::: {.fragment .highlight-current-red fragment-index=7}
Spontaneous coronary artery dissection?
:::

:::
::::

## Differential {.smallest}

:::: {.columns}
::: {.column width="33%"}

::: {.fragment fragment-index=1}
::: {.fragment .highlight-current-red fragment-index=3}
__[Genetic]{.underline}__
:::
:::

::: {.fragment fragment-index=1}
TTN   
LMNA   
MYH7   
FLNC (filamin C)  
RBM20 (RNA-binding motif-20)  
TNNT2  
TTNC1  
PLN (phospholamban)  
DSP (desmoplakin)  
ACTC1  
SCN5A  
TPM1 (tropomyosin)  
:::

:::
::: {.column width="33%"}

::: {.fragment fragment-index=1}
__[Infectious]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=1}
COVID/viral myocarditis  
Chagas disease  
Endomyocardial fibrosis  
:::
:::

::: {.fragment fragment-index=1}
__[Immune-mediated]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=1}
Giant-cell myocarditis  
Eosinophilic myocarditis  
Sarcoidosis  
:::
:::

::: {.fragment fragment-index=1}
__[Ischemic]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=2}
Plaque rupture syndrome  
Coronary artery spasm  
:::
::: {.fragment .highlight-current-red fragment-index=3}
Spontaneous coronary artery dissection  
:::
:::

:::
::: {.column width="33%"}


::: {.fragment fragment-index=1}
__[Others]{.underline}__
:::

::: {.fragment fragment-index=1}
::: {.fragment .semi-fade-out fragment-index=1}
Thiamine deficiency (beri-beri)  
Selenium deficiency  
Hypocalcemia  
Hyper/hypo-thyroidism  
:::
::: {.fragment .semi-fade-out fragment-index=2}
Tachycardia-induced  
:::

::: {.fragment .semi-fade-out fragment-index=1}
Alcohol-induced  
Amphetamine-induced  
Catecholamine-induced (stress-induced, e.g. *Takotsubo*)  
:::

::: {.fragment .highlight-current-red fragment-index=3}
Anabolic steroid-induced  
:::

::: {.fragment .semi-fade-out fragment-index=1}
Hemochromatosis  
Wilson's disease  
:::
:::

:::
::::

# Clinical Course

## {.smaller}

:::: {.columns}
::: {.column width="50%"}
Hospitalization: 

1. Patient was admitted to the cardiology service
1. Nephrology and endocrine consultation
1. Underwent coronary angiography and right heart catheterization
1. Underwent cardiac magnetic resonance imaging
1. Discharged with LifeVest
:::
::: {.column width="50%"}
Treatment: 

- [cessation of AAS]{.red}
- atorvastatin 20
- apixaban 5 bid
- sacubitril-valsartan 24/26
- empagliflozin 10 
:::
::::

# Thoughts? 

# References {.smallest}

::: {#refs}
:::
